The ubiquitin-proteasome pathway

被引:111
|
作者
Roos-Mattjus, P
Sistonen, L
机构
[1] Abo Akad Univ, Turku Ctr Biotechnol, Dept Biol, FIN-20520 Turku, Finland
[2] Univ Turku, SF-20500 Turku, Finland
关键词
cancer; HIF-1; alpha; p53; proteasome; SUMO; ubiquitin;
D O I
10.1080/07853890310016324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulating protein stability and turnover is a key task in the cell. Besides lysosomes, ubiquitin-mediated proteasomal degradation comprises the major proteolytic pathway in eukaryotes. Proteins destined for degradation by the proteasome are conjugated by a 'tag', a ubiquitin chain to a lysine, through an extensively regulated enzymatic cascade. The ubiquitylated proteins are subsequently targeted for degradation by the 26S proteasome, the major proteolytic machinery for ubiquitylated proteins in the cell. Ubiquitylation can be considered as another covalent posttranslational modification and signal, comparable to acetylation. glycosylation, methylation, and phosphorylation. However, ubiquitylation has multiple roles in addition to targeting proteins for degradation. Depending on the number of ubiquitin moieties and the linkages made, ubiquitin also plays an important role in DNA repair, protein sorting and virus budding. Unregulated degradation of proteins, or abnormally stable proteins, interfere with several regulatory pathways, and the ubiquitin-proteasome pathway is affected in a number of diseases, such as neurodegenerative diseases, cellular atrophies and malignancies. Therefore, dissecting the ubiquitin-proteasome pathway and identifying proteins involved in conjunction with the signals required for specific degradation of certain substrates, would help in developing novel therapeutic approaches to treat diseases where the ubiquitin-proteasome pathway is impaired.
引用
收藏
页码:285 / 295
页数:11
相关论文
共 50 条
  • [1] Ubiquitin-proteasome pathway
    Rivett, AJ
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2004, 5 (03)
  • [2] The ubiquitin-proteasome pathway and proteasome inhibitors
    Myung, J
    Kim, KB
    Crews, CM
    [J]. MEDICINAL RESEARCH REVIEWS, 2001, 21 (04) : 245 - 273
  • [3] THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY
    CIECHANOVER, A
    [J]. CELL, 1994, 79 (01) : 13 - 21
  • [4] The ubiquitin-proteasome pathway in cancer
    V Spataro
    C Norbury
    AL Harris
    [J]. British Journal of Cancer, 1998, 77 : 448 - 455
  • [5] The ubiquitin-proteasome pathway in cancer
    Spataro, V
    Norbury, C
    Harris, AL
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (03) : 448 - 455
  • [6] Ubiquitin-Proteasome Pathway and Muscle Atrophy
    Khalil, Rania
    [J]. MUSCLE ATROPHY, 2018, 1088 : 235 - 248
  • [7] Ubiquitin-Proteasome Pathway and Prostate Cancer
    Chen, Fang-Zhi
    Zhao, Xiao-Kun
    [J]. ONKOLOGIE, 2013, 36 (10): : 592 - 596
  • [8] The role of the ubiquitin-proteasome pathway in apoptosis
    Orlowski, RZ
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (04): : 303 - 313
  • [9] The ubiquitin-proteasome pathway of intracellular proteolysis
    Doherty, FJ
    Dawson, S
    Mayer, RJ
    [J]. PROTEASES IN BIOLOGY AND MEDICINE, 2002, 38 : 51 - 63
  • [10] Degradation of BACE by the ubiquitin-proteasome pathway
    Qing, H
    Zhou, WH
    Christensen, MA
    Sun, XL
    Tong, YG
    Song, WH
    [J]. FASEB JOURNAL, 2004, 18 (11): : 1571 - +